Cargando…
CSF synaptic protein concentrations are raised in those with atypical Alzheimer’s disease but not frontotemporal dementia
BACKGROUND: Increased CSF levels of a number of synaptic markers have been reported in Alzheimer’s disease (AD), but little is known about their concentrations in frontotemporal dementia (FTD). We investigated this in three synaptic proteins, neurogranin, SNAP-25, and synaptotagmin-1. METHODS: CSF s...
Autores principales: | Clarke, Mica T. M., Brinkmalm, Ann, Foiani, Martha S., Woollacott, Ione O. C., Heller, Carolin, Heslegrave, Amanda, Keshavan, Ashvini, Fox, Nick C., Schott, Jonathan M., Warren, Jason D., Blennow, Kaj, Zetterberg, Henrik, Rohrer, Jonathan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918699/ https://www.ncbi.nlm.nih.gov/pubmed/31847891 http://dx.doi.org/10.1186/s13195-019-0564-2 |
Ejemplares similares
-
Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest
por: Foiani, Martha S, et al.
Publicado: (2019) -
Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup
por: Woollacott, Ione O. C., et al.
Publicado: (2018) -
Plasma tau is increased in frontotemporal dementia
por: Foiani, Martha S, et al.
Publicado: (2018) -
Stability of blood-based biomarkers of Alzheimer's disease over multiple freeze-thaw cycles
por: Keshavan, Ashvini, et al.
Publicado: (2018) -
CSF pro-orexin and amyloid-β38 expression in Alzheimer's disease and frontotemporal dementia
por: Heywood, Wendy E., et al.
Publicado: (2018)